Introduction
============

Intrauterine environmental exposures to endogenous or exogenous hormones, notably estrogens, may influence the subsequent development of breast cancer in offspring \[[@B1]\]. During pregnancy, levels of circulating estrogens and other hormones with growth-enhancing properties are at least 10 times higher than those in nonpregnant women, with increases seen with advancing gestational age \[[@B2]-[@B4]\]. The hypothesis that breast cancer in daughters may be influenced by the intrauterine environment is receiving increased attention \[[@B5]\]. Perinatal factors, including birth weight, birth order, maternal age, gestational age, twin status, and parental smoking, have been postulated as risk factors for breast cancer through altered hormonal influences on the developing fetal mammary glands \[[@B1]\]. Despite ample biologic plausibility, this hypothesis is difficult to evaluate directly \[[@B5]\], and previous epidemiologic studies have reported conflicting results \[[@B6],[@B7]\].

Here we review the epidemiologic studies that have assessed the association between perinatal factors and breast cancer risk in daughters. A meta-analytical approach was applied in order to clarify further the possible role played by the intrauterine environment in the etiology of breast cancer.

Materials and methods
=====================

Identification of studies
-------------------------

The data retrieved for the systematic review were based on searches of all published papers, letters, abstracts, and review articles on birth weight, birth order, maternal age, gestational age, twin status, and maternal or paternal smoking and breast cancer using the MEDLINE database from January 1966 through February 2007. We used keywords combining text words, with terms for six perinatal factors combined with terms for breast cancer (Table [1](#T1){ref-type="table"}). We also manually searched the reference lists of all studies that fulfilled the inclusion criteria for further relevant publications. Articles were included in our systematic review if they fulfilled the following three criteria: the exposure status of at least one of six perinatal risk factors of interest was compared with nonexposure status; the outcome focused on the daughter\'s breast cancer morbidity or mortality using an epidemiologic study design (case-control design, data linkage study, or cohort study design); and the article was written in English language. We excluded animal studies, investigations focusing on male breast cancer, reviews, and studies that did not provide separate relative risks for breast cancer. We also excluded studies if odds ratios (ORs) or relative risks (RRs) were not specifically provided, raw data were not available for calculation of risks, or the emphasis of analyses was on hazard ratios or standardized incidence ratios.

###### 

Search terms used in systematic review

  Subject            Search term
  ------------------ --------------------------------------------------------------------------------------------------------
  Breast neoplasm    Breast neoplasms, subsequent breast neoplasm, breast neoplasm and daughter
  Birth weight       Cirth weight, birthweight, birth size
  Birth order        Birth order, birth rank
  Maternal age       Maternal age, mother\'s age, parental age
  Gestational age    Gestational age, preterm, prematurity, abruption placenta, pre-eclampsia, eclampsia
  Twinship           Twin, twining, multiple births, multiple pregnancy, monozygote twin, dizygote twin,
  Parental smoking   Maternal smoking, mother\'s smoking, paternal smoking, father\'s smoking, parental smoking
  Others             Prenatal factors, perinatal factors, intrauterine environment, intrauterine factor, *In-utero*exposure

Statistical analyses
--------------------

For the purposes of meta-analysis, birth weight was classified in three different ways: five categories (\<2,500 g, 2,500 to 2,999 g \[referent\], 3,000 to 3,499 g, 3,500 to 3,999 g, and ≥4,000 g); three categories (\<3,000 g \[referent\], 3,001 to 3,999 g, and ≥4,000 g); and two categories (\<3,000 g \[or ≤3,000 g; referent\] and ≥3,000 g \[or \>3,000 g\]). Birth order was examined using two different categorical schemes: 1 (referent) versus ≥2; and 1 (referent), 2 to 4, and ≥5. Maternal age was classified into three categories: \<25 years old (referent), 25 to 29 years old, and ≥30 years old. Gestational age was also analyzed in two ways: ≤36 weeks versus ≥37 weeks (referent); and ≤32 weeks versus ≥33 weeks (referent). To examine twin status, three classification schemes were employed: twin versus singleton (referent); monozygotic twin (or sister twins if zygosity was not reported) versus singleton (referent); and dizygotic twin (or sister-brother twins if zygosity was not reported) versus singleton (referent). Maternal or paternal smoking was considered as follows: no smoking during pregnancy (referent) versus smoking during pregnancy. If the criteria utilized in an article were slightly different from our criteria, then we included the data and described the difference in a footnote.

ORs and 95% confidence intervals (CIs) were recalculated from published frequency tables of individual studies using the Mantel-Haenszel common OR estimate. However, the reported OR (95% CI) was used when the published studies did not provide further details as to the frequencies of the exposure variables. If the manuscript reported the results after performing a stratified analysis, then we re-calculated the crude OR by combining across strata. A random-effects model was used to obtain summary ORs and 95% CIs.

Heterogeneity was assessed by heterogeneity test using Cochran Q statistics \[[@B8]\]. Publication bias was assessed according to the Egger regression asymmetry test, and the Begg and Mazumdar adjusted rank correlation tests \[[@B9],[@B10]\]. The Egger test is a simple linear regression of the natural log of ORs or RRs against its precision (the inverse of its standard error) \[[@B10]\]. The Begg and Mazumdar rank correlation test reports the rank correlation (Kendall\'s tau) between the standardized effect size and the standard errors of these effects. If asymmetry is caused by publication bias, then we would expect that high standard errors (small studies) would be associated with larger effect sizes (ORs or RRs) or low standard errors (large studies) would be associated with smaller effect sizes \[[@B9]\]. The Begg and Mazumdar test makes fewer assumptions than does the Egger test, but it is insensitive to many types of bias (lower power) that the Egger test is sensitive to \[[@B11]\].

When significant heterogeneity or publication bias was found, we performed subgroup analyses by study design (case-control study versus cohort study), and the source of information (data linkage versus self-report) to assess the impact on between-study variations (heterogeneity). Many of the large-scale studies, especially cohort studies, were published after 2000; thus, we classified publication years into before 2000 versus 2000 or later in order to assess publication biases associated with small study sizes. Few studies focused on either Asians or African-Americans, and so it was not possible to examine ethnicity effects. All statistical analyses were conducted using STATA (Version 8.2 \[special edition\]; Stata Corp., College Station, TX, USA).

Results
=======

We identified 34 studies that assessed the association between birth weight and breast cancer risk (Table [2](#T2){ref-type="table"}): 19 case-control studies (eight population based, three nested, six record linkage based, and two twin-based) and 15 cohort studies (seven population based and eight record linkage based). Many studies showed positive association between heavier birth weight and breast cancer risk \[[@B12]-[@B31]\], and some of the studies observed stronger effects among younger (\<45 years) or premenopausal women \[[@B14],[@B22],[@B29],[@B30]\]. In contrast, studies observing no association \[[@B32]-[@B41]\] or a negative one \[[@B42]-[@B45]\] also have been reported. Additionally, some authors reported a J-shaped relationship between birth weight and breast cancer risk \[[@B12],[@B14],[@B15],[@B18],[@B25],[@B33],[@B35],[@B37],[@B45]\], particularly for early-onset cancers \[[@B18]\].

###### 

Studies assessing the association of birth weight and the risk for breast cancer

  Type of study          Ref.        Year   Design    Cases   Controls (or cohort)   Country/place of study   Birthweight (g)           OR (95% CI)          Comments
  ---------------------- ----------- ------ --------- ------- ---------------------- ------------------------ ------------------------- -------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Case-control studies   \[42\]      1988   PCC       153     461                    USA                      1,162--2,948              Referent             Matched analysis; *P*for trend = 0.41
                                                                                                              2,949--3,340              0.65 (0.33--1.26)    
                                                                                                              3,341--4,451              0.76 (0.41--1.43)    
                         \[12\]^a^   1992   LCC       458     1,197                  Sweden                   \<2,500                   1.18 (0.60--2.33)    Adjusted for age and birth date
                                                                                                              2,500--2,999              Referent             
                                                                                                              3,000--3,499              1.29 (0.90--1.91)    
                                                                                                              3,500--3,999              1.47 (1.00--2.18)    
                                                                                                              ≥ 4,000                   1.23 (0.80--2.00)    
                         \[13\]      1996   NCC       550     1,478                  USA                      \<2,500                   0.56 (0.34--0.93)    Adjusted for age
                                                                                                              2,500--2,999              0.68 (0.47--0.99)    
                                                                                                              3,000--3,499              0.71 (0.50--0.99)    
                                                                                                              3,500--3,999              0.85 (0.59--1.22)    
                                                                                                              ≥ 4,000                   Referent             
                         \[14\]      1996   PCC       922     1,194                  USA                      Age 21--45 years:                              Adjusted for age, menopausal status, and maternal smoking; *P*for trend = 0.06 among both groups. The OR (95% CI) for birth weight ≥ 4,000 g among patients with early-onset breast cancer (≤ 30 years old) was 3.3 (1.0--11.0)
                                                                                                               \<2,500                  1.3 (0.9--2.0)       
                                                                                                               2,500--2,999             Referent             
                                                                                                               3,000--3,499             1.3 (1.0--1.7)       
                                                                                                               3,500--3,999             1.2 (0.8--1.6)       
                                                                                                               ≥ 4,000                  1.7 (1.1--2.5)       
                                                                                                              Age 50--64 years:                              
                                                                                                              \<2,500                   0.9 (0.5--1.7)       
                                                                                                              2,500--2,999              Referent             
                                                                                                              3,000--3,499              1.1 (0.7--1.7)       
                                                                                                              3,500--3,999              0.8 (0.4--1.3)       
                                                                                                              ≥ 4,000                   0.6 (0.3--1.1)       
                         \[32\]      1997   NCC       1068    2,027                  Sweden                   \<2,500                   0.80 (0.50--1.26)    Adjusted for maternal age, socioeconomic status, parity, and pre-eclampsia or eclampsia, neonatal jaundice, severe prematurity, and twinship
                                                                                                              2,500--2,999              Referent             
                                                                                                              3,000--3,499              1.00 (0.79--1.28)    
                                                                                                              3,500--3,999              0.99 (0.77--1.26)    
                                                                                                              ≥ 4,000                   1.04 (0.77--1.41)    
                         \[33\]      1998   PCC       510     436                    USA                      \<2,500                   1.2 (0.7--2.1)       Crude ORs
                                                                                                              2,500--2,999              Referent             
                                                                                                              3,000--3,499              1.0 (0.7--1.5)       
                                                                                                              3,500--3,999              1.0 (0.7--1.5)       
                                                                                                              ≥ 4,000                   1.3 (0.7--2.3)       
                         \[15\]      2000   LCC       484     2,870                  USA                      \<1,500                   1.59 (0.61--4.11)    Crude ORs
                                                                                                              1,500--2,499              1.33 (0.94--1.90)    
                                                                                                              2,500--3,499              Referent             
                                                                                                              3,500--4,499              1.08 (0.87--1.34)    
                                                                                                              ≥ 4,500                   3.29 (1.37--7.92)    
                         \[34\]      2001   LTCC      87      87                     Sweden                   \<1,999                   Referent             Matched analysis by conditional logistic regression
                                                                                                              2,000--2,499              1.6 (0.6--4.0)       
                                                                                                              2,599--2,999              2.4 (0.9--6.2)       
                                                                                                              ≥ 3,000                   1.6 (0.4--5.6)       
                                                                                                                                        (*P*trend = 0.05)    
                         \[43\]      2001   LCC       319     768                    USA                      \<2,500                   1.4 (0.55--3.4)      Crude ORs. Higher birth weight (≥ 3,500 g) carried a marginal significantly higher risk for breast cancer (OR 1.76 \[95% CI 0.90--3.35\]) relative to lower birth weight (\<3,500 g)
                                                                                                              2,500--3,750              Referent             
                                                                                                              ≥ 3,750                   0.9 (0.50--1.6)      
                         \[16\]      2001   LTCC      90      90                     Sweden                   ≤ 2,000                   Referent             Crude ORs. Study subjects were women with opposite-sexed pair twins
                                                                                                              2,001--2,500              3.2 (0.8--12.6)      
                                                                                                              2,501--3,000              3.5 (1--13)          
                                                                                                              3,001--3,500              5.8 (1.3--25.7)      
                                                                                                              ≥ 3,501                   12.1 (1.1--138.8)    
                         \[35\]      2002   PCC       2,088   2,187                  USA                      \<2,500                   1.10 (0.90--1.35)    Adjusted for age and residential regions (states)
                                                                                                              2,500--2,999              0.90 (0.70--1.10)    
                                                                                                              3,000--3,499              Referent             
                                                                                                              3,500--3,999              1.07 (0.90--1.30)    
                                                                                                              4,000--4,499              0.89 (0.70--1.14)    
                                                                                                              ≥ 4,500                   1.18 (0.90--1.51)    
                         \[44\]      2002   PCC       288     350                    China                    \<2,500                   0.9 (0.4--2.0)       Adjusted for age income, family history of breast cancer in first-degree relative, history of fibroadenoma, age at menarche, parity, and age at first live birth.
                                                                                                              2,500--2,999              Referent             
                                                                                                              3,000--3,499              1.1 (0.8--1.6)       
                                                                                                              3,500--3,999              0.8 (0.4--1.4)       
                                                                                                              ≥ 4,000                   0.7 (0.4--1.4)       
                         \[17\]      2002   LCC       373     1,150                  USA                      \<3,090                   Referent             Adjusted for parity and age at first birth. *P*for trend = 0.02
                                                                                                              3,090--3,410              1.1 (0.8--1.5)       
                                                                                                              3,420--3,720              1.2 (0.9--1.6)       
                                                                                                              ≥ 3,630                   1.4 (1.1--1.9)       
                         \[18\]      2003   LCC       881     3,423                  Denmark                  \<2,500                   1.66 (1.00--2.51)    Adjusted for mother\'s marital status, maternal age, and birth order
                                                                                                              2,500--2,999              0.83 (0.60--1.10)    
                                                                                                              3,000--3,499              Referent             
                                                                                                              3,500--3,999              0.98 (0.80--1.17)    
                                                                                                              ≥ 4,000                   1.25 (1.00--1.55)    
                         \[19\]      2004   NCC       89      238                    Sweden                   100 g increase            1.06 (1.00--1.12)    Adjusted for gestational age, birth year, and maternal hypertension/proteinuria
                         \[45\]      2004   LCC       2471    9801                   USA                      \<1,500                   0.64 (0.40--1.11)    Adjusted for age and maternal age at first birth
                                                                                                              1,500--1,999              1.05 (0.70--1.68)    
                                                                                                              2,000--2,499              1.02 (0.80--1.31)    
                                                                                                              2,500--3,499              Referent             
                                                                                                              3,500--3,999              0.97 (0.90--1.08)    
                                                                                                              4,000--4,499              0.93 (0.80--1.11)    
                                                                                                              ≥ 4,500                   0.69 (0.40--1.09)    
                         \[36\]      2004   PCC       196     167                    USA                      All subjects:                                  Adjusted for age, race and sampling fractions, body mass index, household income, and maternal age. Tertiles are race specific with cutpoints derived from controls. White women: \<3,062, 3,062--3,458, \>3,458 g; black women: \<3,146, 3,146--3,488, \>3,488 g. Restricted data using birth weight measured in pounds and ounces and participant delivered in a medical facility by a physician
                                                                                                               Lower tertile            1.0 (0.6--1.7)       
                                                                                                               Central tertile          Referent             
                                                                                                               Upper tertile            0.7 (0.4--1.2)       
                                                                                                              White, restricted                              
                                                                                                              data:                                          
                                                                                                               Lower tertile            1.1 (0.5--2.4)       
                                                                                                               Central tertile          Referent             
                                                                                                               Upper tertile            1.4 (0.6--2.0)       
                         \[20\]      2006   PCC       2,386   2,502                  Poland                   \<2,500                   Referent             Adjusted for: age, education, age at menarche, menopausal status and age at menopause, age at first full-term pregnancy, number of full-term pregnancies, family history of breast cancer among first-degree relatives, mammography screening, and current body mass index. Lower birth weight (\<2,500 g) carries greater risk than birth weight of 2,500--4,000 g among women under 45 years old
                                                                                                              2,500--4,000              1.22 (0.92--1.62)    
                                                                                                              \>4,000                   1.54 (1.08--2.19)    
                                                                                                                                        (*p*-trend = 0.01)   
                         \[37\]      2006   PCC       1,166   2,105                  USA                      \<2,495                   1.19 (0.85--1.66)    Adjusted for age (years), education (years), race, body mass index, history of breast benign disease, family history of breast cancer, lactation (months), age at menarche (years), age at first full-term pregnancy (years), age at menopause (years), parity
                                                                                                              2,495--3,130              Referent             
                                                                                                              3,131--3,855              0.97 (0.75--1.25)    
                                                                                                              \>3,855                   1.03 (0.74--1.44)    
                                                                                                                                                             
  Cohort studies         \[21\]      1999   LCohort   57      152,590                Sweden                   \<2,500                   Referent             Standardization for sex, age, and age-specific incidence rate
                                                                                                              2,500--3,999              1.3 (0.6--2.4)       
                                                                                                              4,000--4,499              1.2 (0.0--6.7)       
                                                                                                              ≥ 4,500                   1.3 (0.7--2.3)       
                         \[22\]      2000   Cohort    37      2,221                  UK                       All ages                                       Adjusted for age. *P*for trend = 0.03 among premenopausal women
                                                                                                               \<3,000                  Referent             
                                                                                                               3,000--3,499             1.05 (0.41--2.71)    
                                                                                                               3,500--3,999             1.76 (0.72--4.33)    
                                                                                                               ≥ 4,000                  2.02 (0.59--6.90)    
                                                                                                              Premenopausal ages                             
                                                                                                               \<3,000                  Referent             
                                                                                                               3,000--3,499             1.99 (0.40--9.86)    
                                                                                                               3,500--3,999             3.26 (0.69--15.36)   
                                                                                                               ≥ 4,000                  5.65 (0.95--33.84)   
                         \[38\]      2001   LCohort   177     3,447                  Sweden                   ≤ 2,000                   Referent             Crude hazard ratios
                                                                                                              2,001--2,500              1.4 (0.6--3.4)       
                                                                                                              2,501--3,000              1.9 (0.8--4.3)       
                                                                                                              3,001--3,500              1.5 (0.6--3.5)       
                                                                                                              ≥ 3,501                   1.9 (0.7--5.0)       
                         \[39\]      2001   Cohort    62      1260                   Sweden                   ≤ 3,000                   Referent             Singleton only; adjusted for gestational age and cohort membership
                                                                                                              3,010--3,349              1.16 (0.47--2.87)    
                                                                                                              3,350--3,590              1.65 (0.71--3.86)    
                                                                                                              3,600--3,960              1.58 (0.67--3.72)    
                                                                                                              ≥ 4,000                   1.57 (0.67--3.64)    
                         \[23\]      2003   LCohort   63      5,352                  Sweden                   \<3,000                   Referent             Crude ORs;*P*for trend = 0.01
                                                                                                              3,000--3,499              1.46 (0.60--3.43)    
                                                                                                              3,500--3,999              2.09 (0.90--4.85)    
                                                                                                              ≥ 4,000                   2.78 (1.10--7.15)    
                         \[24\]      2003   LCohort   2,334   106,504                Denmark                  1,000 g increase          9 (0.02--17)%        Adjusted for age and calendar period. Additional adjustment for parity and age at first birth did not indicate confounding
                         \[25\]      2003   LCohort   39      1483                   Sweden                   500--1,999                1.14 (0.70--1.85)    Standardized incidence ratio (expected/observed)
                                                                                                              2,000--2,999              0.71 (0.40--1.15)    
                                                                                                              ≥ 3,000                   2.55 (1.03--5.25)    
                         \[26\]^a^   2004   LCohort   2,074   91,601                 Denmark                  Median of each quintile                        Adjusted for age and calendar period. No change in estimates when additionally adjusted for parity and age at first birth
                                                                                                               2.5                      Referent             
                                                                                                               3.0                      0.98 (0.85--1.13)    
                                                                                                               3.4                      1.06 (0.93--1.20)    
                                                                                                               3.6                      1.05 (0.87--1.27)    
                                                                                                               4.0                      1.17 (1.02--1.33)    
                         \[27\]      2004   Cohort    59      2,176                  UK                       \<3,000                   Referent             Adjusted for age; *P*for trend = 0.03
                                                                                                              3,000--3,499              1.37 (0.34--5.47)    
                                                                                                              3,500--3,999              2.18 (0.58--8.21)    
                                                                                                              ≥ 4,000                   5.03 (1.13--22.47)   
                         \[28\]      2005   LCohort   311     16,011                 USA                      \<3,040                   Referent             Adjusted for year of birth
                                                                                                              3,040--3,310              1.4 (1.0--2.1)       
                                                                                                              3,320--3,550              1.0 (0.6--1.5)       
                                                                                                              3,560--3,830              1.3 (0.9--1.9)       
                                                                                                              ≥ 3,840                   1.5 (1.0--2.2)       
                         \[29\]^a^   2005   LCohort   367     5,346                  Sweden                   \<50 years                                     
                                                                                                               \<3,000                  Referent             
                                                                                                               3,000--3,499             1.81 (0.77--4.26)    
                                                                                                               3,500--3,999             2.66 (1.09--6.46)    
                                                                                                               ≥ 4,000                  4.00 (1.49--10.72)   
                                                                                                              ≥ 50 years                                     
                                                                                                               \<3,000                  Referent             
                                                                                                               3,000--3,499             0.86 (0.62--1.19)    
                                                                                                               3,500--3,999             1.06 (1.20--3.34)    
                                                                                                               ≥ 4,000                  0.91 (0.57--1.46)    
                         \[40\]      2006   Cohort    97      5,847                  USA                      \<3,000                   0.98 (0.61--1.60)    Adjusted for age
                                                                                                              3,000--3,499              Referent             
                                                                                                              ≥ 3,500                   1.09 (0.66--1.80)    
                         \[30\]      2006   Cohort    3,140   91,601                 USA                      Premenopause                                   Adjusted for age: *P*for trend = 0.019
                                                                                                               \<2,495                  0.69 (0.50--0.94)    
                                                                                                               2,495--3,130             0.79 (0.64--0.97)    
                                                                                                               3,131--3,810             0.76 (0.63--0.93)    
                                                                                                               \>3,810                  Referent             
                                                                                                              Postmenopause:                                 Adjusted for age: *P*for trend = 0.99
                                                                                                               \<2,495                  1.04 (0.88--1.23)    
                                                                                                               2,495--3,130             1.00 (0.87--1.14)    
                                                                                                               3,131--3,855             1.05 (0.93--1.20)    
                                                                                                               \>3,855                  Referent             
                         \[31\]      2006   Cohort    209     1,024                  USA                      \<2,500                   0.9 (0.5--1.6)       Hazard ratio; adjusted for age at diagnosis, diagnosis year, stage at diagnosis, and birth order, with exception of birth order, which is adjusted for maternal age
                                                                                                              2,500--3,999              Referent             
                                                                                                              ≥ 4,000                   1.8 (1.0--3.1)       
                                                                                                                                        (*P*trend = 0.1)     
                         \[41\]      2007   Cohort    657     38,566                 Sweden                   \<2,500                   0.65 (0.43--0.99)    Adjusted for adult body mass index
                                                                                                              2,500--3,000              1.04 (0.86--1.25)    
                                                                                                              \>3,000                   Referent             

Cohort, cohort study; LCC, case-control study with linkage with population and cancer registry data; LCohort, cohort study with linkage with population and cancer registry data; LTCCS, twin case-control study by using linkage with birth and cancer registry data; NCC, nested case-control study in cohort; PCC, population-based case-control study. ^a^The numbers of cases and controls were not shown in the original article.

Among 34 studies of birth weight and breast cancer, we selected studies that employed the same categories of birth weight. To evaluate whether a J-shaped relationship existed, we grouped birth weight into more than three categories. The findings of meta-analysis of eight studies that utilized five categories of birth weight (\<2,500, 2,500 to 2,999, 3,000 to 3,499, 3,500 to 3,999, and ≥4,000 g) and 11 studies that used three categories (\<3,000, 3,000 to 3,999, and ≥4,000 g) are shown in Figures [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}. To include more studies, we also categorized birthweights as \<3,000 g (or ≤3,000 g) and ≥3,000 g (or \>3,000 g; Figure [3](#F3){ref-type="fig"}). Sixteen studies among all 34 studies were included in the meta-analyses for birth weight and breast cancer: seven studies \[[@B13],[@B14],[@B18],[@B32],[@B33],[@B35],[@B44]\] were included in the all three meta-analyses; four studies \[[@B22],[@B23],[@B27],[@B39]\] were included in the two of the three meta-analyses; and five studies were included in only one meta-analysis \[[@B12],[@B16],[@B28],[@B34],[@B38]\]. There was no significant heterogeneity across studies (*P\_*Q test \> 0.05 for all categories). In the five-category meta-analysis, ORs were 1.11 (95% CI 0.90 to 1.33) for birth weight \<2,500 g, 1.11 (0.99 to 1.25) for 3,000 to 3,499 g, 1.15 (1.04 to 1.26) for 3,500 to 3,999 g, and 1.24 (1.04 to 1.48) for ≥4,000 g relative to the referent category of 2,500 to 2,999 g. In the three-category meta-analysis, ORs were 1.06 (95% CI 0.98 to 1.14) for 3,000 to 3,999 g and 1.15 (1.01 to 1.31) for ≥4,000 g relative to the referent category of \<3,000 g. In the two-category meta-analysis, ORs were 1.09 (95% CI 1.02 to 1.18) for the category of \>3,000 g (or ≥3,000 g) relative to the referent category of ≤3,000 g (or \<3,000 g).

We identified 17 studies (15 case-control and two cohort) that assessed the association between birth order and breast cancer risk (Table [3](#T3){ref-type="table"}). Eight of the studies reported an inverse relationship \[[@B14],[@B20],[@B31],[@B35],[@B36],[@B42],[@B46],[@B47]\]. Some studies found significantly lower risks for second or later born children versus first-born children \[[@B31],[@B46]\]. Some studies found significantly or marginally significantly reduced risk among women whose birth had been preceded by the birth of at least five siblings \[[@B20],[@B35]\]. Other several studies noted an increased risk associated with higher birth order \[[@B15],[@B37],[@B48],[@B49]\], whereas some studies failed to observe such an association \[[@B12],[@B18],[@B32],[@B50]\]. One study did not supply the estimated risk but describe the *P*value by the mean difference of birth order \[[@B51]\].

###### 

Studies assessing the association of birth order and the risk of breast cancer

  Type of study          Ref.        Year   Design   Cases   Controls (or cohort)   Country/place of study                 Birth order        OR (95% CI)            Comments
  ---------------------- ----------- ------ -------- ------- ---------------------- -------------------------------------- ------------------ ---------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Case-control studies   \[51\]      1967   LCC-D    229     229                    USA                                    1                  \-                     The authors measured the mean value of birth weight instead of providing ORs (95% CIs). The mean difference between cases and matched controls was not significant (*P*\> 0.2). They provided the frequency of each case and control in the tables and we calculated crude ORs
                                                                                                                           2                                         
                                                                                                                           3                                         
                                                                                                                           4                                         
                                                                                                                           5                                         
                                                                                                                           6                                         
                                                                                                                           ≥ 7                                       
                         \[50\]^a^   1980   MCC      4339    12,760                 USA, Japan, Slovenia, Athens, Taipei   1                  Referent               The risks (point estimates) only by birth order were shown in the figure in the original article.
                                                                                                                           2                  0.93                   
                                                                                                                           3                  1.08                   
                                                                                                                           4                  0.99                   
                                                                                                                           5                  1.05                   
                                                                                                                           6                  1.07                   
                                                                                                                           7                  1.18                   
                                                                                                                           ≥ 8                1.02                   
                         \[42\]      1988   PCC      153     461                    USA                                    1                  Referent               *P*for trend = 0.16
                                                                                                                           2                  0.92 (0.55--1.54)      
                                                                                                                           3                  0.98 (0.58--1.72)      
                                                                                                                           4                  0.69 (0.36--1.32)      
                                                                                                                           ≥ 5                1.03 (0.60--1.79)      
                         \[46\]      1991   MCC      927     2,616                  USA/Wales/Japan                        All ages                                  Adjusted for age, study center, parity, age at first birth, age at menarche, height, body mass index, maternal age at birth, and menopausal status
                                                                                                                            1                 Referent               
                                                                                                                            2                 0.91 (0.73--1.02)      
                                                                                                                            3                 1.11 (0.87--1.27)      
                                                                                                                            ≥ 4               1.09 (0.81--1.18)      
                                                                                                                           Premenopausal                             
                                                                                                                            1                 Referent               
                                                                                                                            ≥ 2               0.76 (0.60--0.96)      
                         \[12\]      1992   LCC      458     1,197                  Sweden                                 1                  Referent               Adjusted for age and birth date
                                                                                                                           ≥ 2                1.00 (0.76--1.32)      
                         \[47\]      1994   PCC      2,414   9,138                  USA                                    1                  Referent               Adjusted for age at first birth and number of children
                                                                                                                           2                  0.90 (0.78--1.03)      
                                                                                                                           3                  0.98 (0.84--1.14)      
                                                                                                                           4                  0.86 (0.73--1.02)      
                                                                                                                           5                  0.93 (0.78--1.11)      
                                                                                                                           6                  1.02 (0.84--1.23)      
                                                                                                                           7                  0.91 (0.73--1.14)      
                                                                                                                           ≥ 8                0.88 (0.75--1.04)      
                         \[14\]      1996   PCC      1,129   1,393                  USA                                    1                  Referent               Adjusted for age, menopausal status, and maternal smoking; *P*for trend = 0.06 among both groups
                                                                                                                           2                  1.0 (0.7--1.4)         
                                                                                                                           ≥ 3                0.8 (0.6--1.1)         
                         \[32\]      1997   NCC      1,068   2,727                  Sweden                                 1                  Referent               Adjusted for maternal age, socioeconomic status, parity, and preeclampsia or eclampsia, neonatal jaundice, severe prematurity, and twinship
                                                                                                                           2                  1.01 (0.83--1.22)      
                                                                                                                           ≥ 3                1.01 (0.81--1.26)      
                         \[15\]      2000   LCC      481     2,863                  USA                                    1                  1.07 (0.84--1.35)      Crude ORs
                                                                                                                           2--3               Referent               
                                                                                                                           4--5               1.06 (0.81--1.38)      
                                                                                                                           ≥ 6                1.50 (1.06--2.13)      
                         \[35\]      2002   PCC      1,555   1,539                  USA                                    1                  Referent               Adjusted for age and residential regions (states)
                                                                                                                           2                  1.07 (0.88--1.30)      
                                                                                                                           3                  1.07 (0.85--1.35)      
                                                                                                                           4                  1.01 (0.77--1.31)      
                                                                                                                           5                  0.66 (0.48--0.92)      
                                                                                                                           ≥ 6                0.81 (0.62--1.08)      
                         \[18\]      2003   LCC      881     3,423                  Denmark                                1                  Referent               Adjusted for mother\'s marital status, maternal age, and birth order
                                                                                                                           ≥ 2                1.01 (0.83--1.12)      
                         \[36\]      2004   PCC      854     785                    USA                                    All subjects                              Adjusted for age, race and sampling fractions, body mass index, hosehold income, maternal age
                                                                                                                            1                 Referent               
                                                                                                                            2--4              0.9 (0.7--1.1)         
                                                                                                                            ≥ 5               1.0 (0.8--1.3)         
                                                                                                                           Born ≥ 1948                               
                                                                                                                            1                 Referent               
                                                                                                                            2--4              0.9 (0.6--1.4)         
                                                                                                                            ≥ 5               0.6 (0.3--1.3)         
                         \[48\]^a^   2005   MCC      24      34                     Nigeria                                ≤ 3                Referent               Crude ORs
                                                                                                                           ≥ 4                1.50 (0.25--8.98)      
                         \[20\]      2005   PCC      1642    1,713                  Poland                                 1                  Referent               Adjusted for age, education, age at menarche, menopausal status and age at menopause, age at first full-term pregnancy, number of full-term pregnancies, family history of breast cancer among first-degree relatives, mammography screening, and current body mass index
                                                                                                                           2                  1.07 (0.91--1.24)      
                                                                                                                           3--5               0.99 (0.85--1.15)      
                                                                                                                           ≥ 6                0.81 (0.61--1.06)      
                                                                                                                                              *P*for trend = 0.81    
                         \[37\]      2006   PCC      1,166   2,105                  USA                                    1                  Referent               Adjusted for age (years), education (years), race, body mass index, history of breast benign disease, family history of breast cancer, lactation (months), age at menarche (years), age at first full-term pregnancy (years), age at menopause (years), parity
                                                                                                                           ≥ 2                1.27 (0.88--1.85)      
  Cohort studies         \[31\]      2006   Cohort   209     1,024                  USA                                    1                  Referent               Hazard ratio for breast cancer mortality: adjusted for age at diagnosis, diagnosis year, stage at diagnosis, and birth order, with exception of birth order, which is adjusted for maternal age
                                                                                                                           2                  0.2 (0.2--0.3)         
                                                                                                                           ≥ 3                0.2 (0.2--0.3)         
                                                                                                                                              *P*for trend \< 0.01   
                         \[49\]^a^   2001   Cohort   \-      \-                     Sweden                                 Continuous scale   1.05 (1.01--1.10)      

^a^We did not include these studies in the meta-analysis because they employed different categories or a continuous scale, or they did not provide the numbers of cases and controls in the original article. Cohort, cohort study; LCC, case-control study with linkage with population and cancer registry data; LCC-D, case-control study with linkage with population and cancer death certification data; MCC, multicenter case-control study; NCC, nested case-control study in cohort; PCC, population-based case-control study.

![Meta-analysis of the association between birth weight (five categories) and risk for breast cancer. The tests for homogeneity and for publication bias in the studies analyzed are as follows. Category I (birth weight \<2,500 g) versus reference: Q = 9.66 (8 degrees of freedom), *P*= 0.29; Begg test, *P*= 0.75; Egger test, *P*= 0.66. Category II (2,500 to 2,999 g) is the reference. Category III (3,000 to 3,499 g) versus reference: Q = 6.53 (8 degrees of freedom), *P*= 0.59; Begg test, *P*= 0.25; Egger test, *P*= 0.46. Category IV (3,500 to 3,999 g) versus reference: Q = 4.17 (8 degrees of freedom), *P*= 0.84; Begg test, *P*= 0.60; Egger test, *P*= 0.93. Category V (≥4,000 g) versus reference: Q = 11.18 (8 degrees of freedom), *P*= 0.19; Begg test, *P*= 0.25; Egger test, *P*= 0.30. ^1^We used adjusted odds ratios (ORs) for meta-analysis because the numbers of cases and controls were not represented in the original article. CI, confidence interval.](bcr1850-1){#F1}

![Meta-analysis of the association between birth weight (three categories) and risk for breast cancer. The tests for homogeneity and for publication bias in the studies analyzed are as follows. Category I (birth weight 3,000 to 3,999 g) versus reference (\<3,000 g): Q = 4.97 (11 degrees of freedom), *P*= 0.93; Begg test, *P*= 0.54; Egger test, *P*= 0.27. Category II (≥4,000 g) versus reference: Q = 13.44 (11 degrees of freedom), *P*= 0.27; Begg test, *P*= 0.54; Egger test, *P*= 0.53. CI, confidence interval; OR, odds ratio.](bcr1850-2){#F2}

![Meta-analysis of the association between birth weight (two categories) and risk for breast cancer. The tests for homogeneity and for publication bias in the studies analyzed are as folows. Reference (\<3,000 g \[or ≤3,000 g\]) versus ≥3,000 g (or \>3,000 g): Q = 11.57 (15 degrees of freedom), *P*= 0.93; Begg test, *P*= 0.15; Egger test, *P*= 0.50. CI, confidence interval; OR, odds ratio.](bcr1850-3){#F3}

For the meta-analysis, we included 14 studies (13 case-control studies and one cohort) that used two birth order categories: 1 (referent) and ≥2. There was significant heterogeneity across all studies (*P\_*Q test \< 0.01), although there was no significant heterogeneity across the case-control studies (*P\_*Q test = 0.90). As shown in Figure [4](#F4){ref-type="fig"}, there was no difference in risk according to birth order across all studies (OR 0.97 \[95% CI 0.91 to 1.04\]) or within the case control studies (OR 0.99 \[95% CI 0.94 to 1.04\]). We calculated the crude odds ratio from the cohort study \[[@B31]\], and the result was very different from the summary OR (calculated crude OR 0.28 \[95% CI 0.21 to 0.36\]). The results of all case-control studies were near null, whereas the cohort study found a significant risk reduction in birth orders of 2 or greater. We also examined the seven studies that classified individuals according to three birth order levels (1 \[referent\], 2 to 4, ≥5; Figure. [4](#F4){ref-type="fig"}). There was significant heterogeneity across studies (all of which were case-control studies) for the highest birth order category (*P\_*Q test = 0.03) Women with a birth order of ≥5 were at nonsignificantly reduced risk compared with first-born women (OR 0.88 \[95% CI 0.75--1.01\]). There was no difference in risk for women of birth orders 2 to 4 (OR 0.97 \[95% CI 0.91--1.03\]).

![Meta-analysis of the association between birth order and risk for breast cancer. The tests for homogeneity and for publication bias in the studies analyzed are as follows. Category I (birth order 2+) versus reference (birth order 1): Q = 87.79 (13 degrees of freedom), *P*\< 0.01; Begg test, *P*= 0.44; Egger test, *P*= 0.46. Category II (birth order 5+ and 2 to 4) versus reference: Q = 4.56 (6 degrees of freedom), *P*= 0.60; Begg test, *P*= 0.37; Egger test, *P*= 0.44. Category II (birth order ≥6, 2 to 5) versus reference: Q = 14.42 (6 degrees of freedom), *P*= 0.60; Begg test, *P*= 0.37; Egger test, *P*= 0.44. ^1^Category I of birth order was 2+ vs 1. ^2^Category II of birth order was composed of two conditions: 5+ and 2 to 4; and ≥6 and 2 to 5 vs 1. ^3^We used adjusted odds ratios (ORs) for meta-analysis because the numbers of cases and controls were not represented in the original article. CI, confidence interval.](bcr1850-4){#F4}

We identified 28 studies (22 case-control and six cohort) that assessed the association between maternal age and breast cancer risk (Table [4](#T4){ref-type="table"}). Seven studies observed modestly increased risks for daughters born to older mothers \[[@B15],[@B31],[@B32],[@B36],[@B42],[@B46],[@B52]\]. A pattern of slight decrease after modest increase in risk was found in five other studies \[[@B50],[@B53]-[@B56]\]. Fourteen studies, however, no association was observed \[[@B12],[@B14],[@B18],[@B20],[@B35],[@B37],[@B38],[@B47],[@B49],[@B57]-[@B60]\]. Two studies did not estimate the risks \[[@B51],[@B61]\].

###### 

Studies assessing the association of maternal age with risk for breast cancer

                         Ref.        Year   Design   Cases   Controls (or cohort)     Country/place of study                 Maternal age (years)   OR (95% CI)           Comments
  ---------------------- ----------- ------ -------- ------- ------------------------ -------------------------------------- ---------------------- --------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Case-control studies   \[51\]      1967   LCC-D    229     229                      USA                                    ≤ 19                                         Mean maternal age among cases was higher than that among controls (*P*\< 0.005). The frequency of each case and control were shown in the tables provided and we calculated crude ORs
                                                                                                                             20--24                                       
                                                                                                                             25--29                                       
                                                                                                                             30--34                                       
                                                                                                                             35--39                                       
                                                                                                                             ≥ 40                                         
                         \[61\]^a^   1974   PCC      308     308                      USA                                                                                 Matched analysis; the mean maternal age was 27.3 years among cases and 26.3 years among controls (*P*\< 0.01)
                         \[50\]^b^   1980   MCC      4339    12760                    USA, Japan, Slovenia, Athens, Taipei   ≤ 19                   Referent              Authors showed point estimates of ORs without 95% CIs. The frequencies for each case and control were given in the tables provided and we calculated crude ORs
                                                                                                                             20--24                 1.05                  
                                                                                                                             25--29                 1.22                  
                                                                                                                             30--34                 1.19                  
                                                                                                                             35--39                 1.31                  
                                                                                                                             ≥ 40                   1.18                  
                         \[53\]^a^   1984   MCC      1,176   1,176                    England                                ≤ 20                   Referent              Adjusted for age, social class, family history of breast cancer, age at first-term birth, past history of benign breast disease, age at menarche, menopausal status, cigarette smoking, and oral contraceptive use
                                                                                                                             21--25                 1.41 (0.92--2.18)     
                                                                                                                             26--30                 1.19 (0.78--1.81)     
                                                                                                                             31--35                 1.29 (0.83--1.98)     
                                                                                                                             ≥ 36                   1.19 (0.68--1.67)     
                         \[42\]^a^   1988   PCC      153     461                      USA                                    All women                                    Matched analysis
                                                                                                                              15--22                1.18 (0.71--1.97)     
                                                                                                                              23--26                Referent              
                                                                                                                              27--30                1.22 (0.71--2.10)     
                                                                                                                              31--46                1.66 (0.99--2.78)     
                                                                                                                                                    *P*for trend = 0.67   
                                                                                                                             Younger women                                
                                                                                                                              15--23                1.39 (0.65--2.95)     
                                                                                                                              24--28                Referent              
                                                                                                                              29--46                2.21 (1.02--4.80)     
                                                                                                                                                    *P*for trend = 0.08   
                         \[52\]^a^   1989   PCC      801     1,573                    USA                                    Continuous             1.24 (1.09--1.41)     Crude OR
                         \[54\]      1990   PCC      2,291   3,144                    USA                                    ≤ 19                   Referent              Adjusted for age and parity, age at first pregnancy, total duration of breast feeding, race, age at menarche, menopausal status, body mass index, family history of breast cancer, and breast biopsy
                                                                                                                             20--24                 0.95 (0.77--1.16)     
                                                                                                                             25--29                 1.13 (0.92--1.38)     
                                                                                                                             30--34                 1.16 (0.93--1.45)     
                                                                                                                             35--39                 1.46 (1.10--1.93)     
                                                                                                                             ≥ 40                   1.20 (0.79--1.83)     
                         \[55\]      1991   PCC      1761    1,116,553 person-years   USA                                    ≤ 19                   Referent              Crude ORs
                                                                                                                             20--24                 1.02 (0.82--1.46)     
                                                                                                                             25--29                 1.12 (1.04--1.38)     
                                                                                                                             30--34                 1.16 (0.93--1.44)     
                                                                                                                             35--39                 1.17 (0.92--1.48)     
                                                                                                                             ≥ 40                   1.08 (0.80--1.46)     
                         \[46\]^a^   1991   MCC      927     2616                     USA, Wales, Japan                      Each 5-yrs             1.06 (1.01--1.10)     Adjusted for age, study center, parity, age at first birth, age at menarche, height, BMI, maternal age at birth, and menopausal status
                         \[12\]^b^   1992   LCC      458     1,197                    Sweden                                 Each 5-year band       1.01 (0.92--1.12)     Adjusted for age and birth date. The authors estimated breast cancer risk according to each 5-year band of maternal age. The frequency of each case and control were given in the tables provided and we calculated crude ORs
                         \[47\]      1994   PCC      2,412   9,138                    USA                                    ≤ 19                   Referent              Adjusted for age at first birth and number of children
                                                                                                                             20--24                 1.05 (0.85--1.30)     
                                                                                                                             25--29                 1.10 (0.89--1.37)     
                                                                                                                             30--34                 1.10 (0.88--1.37)     
                                                                                                                             35--39                 1.09 (0.87--1.37)     
                                                                                                                             ≥ 40                   0.99 (0.76--1.28)     
                         \[14\]      1996   PCC      1,934   2,161                    USA                                    ≤ 24                   Referent              Adjusted for age, menopausal status, and maternal smoking
                                                                                                                             25--29                 1.0 (0.8--1.2)        
                                                                                                                             30--34                 0.9 (0.6--1.1)        
                                                                                                                             ≥ 35                   1.0 (0.7--1.5)        
                         \[57\]      1997   PCC      1,253   1,121                    USA                                    ≤ 19                   Referent              Adjusted for age, menopausal status, age at menarche, parity, age at first birth, body mass index, past history of benign breast disease, and recent alcohol intake
                                                                                                                             20--24                 0.84 (0.62--1.14)     
                                                                                                                             25--29                 1.02 (0.76--1.37)     
                                                                                                                             30--34                 0.93 (0.68--1.28)     
                                                                                                                             35--39                 1.16 (0.82--1.65)     
                                                                                                                             ≥ 40                   0.92 (0.62--1.37)     
                         \[58\]      1997   PCC      2,106   1,926                    USA                                    ≤ 19                   Referent              Adjusted for age, study site, family history of breast cancer, breast biopsy, a combination variable including number of full-term births and age at first full-term pregnancy, age at menarche, menopausal status, body mass index, average lifetime alcohol consumption, and the number of mammograms
                                                                                                                             20--24                 0.96 (0.7--1.2)       
                                                                                                                             25--29                 0.96 (0.7--1.2)       
                                                                                                                             30--34                 0.91 (0.7--1.2)       
                                                                                                                             ≥ 35                   0.93 (0.7--1.3)       
                         \[32\]^a^   1997   NCC      1,067   2,725                    Sweden                                 Each 5-year band       1.06 (0.99--1.14)     Adjusted for maternal age, socioeconomic status, parity, and pre-eclampsia or eclampsia, neonatal jaundice, severe prematurity, and twinship
                         \[15\]      2000   LCC      481     2863                     USA                                    ≤ 19                   1.19 (0.83--1.72)     Crude ORs
                                                                                                                             20--24                 Referent              
                                                                                                                             25--29                 1.26 (0.97--1.64)     
                                                                                                                             30--34                 1.38 (1.04--1.84)     
                                                                                                                             ≥ 35                   1.70 (1.23--2.35)     
                         \[35\]      2002   PCC      1,555   1,539                    USA                                    ≤ 19                   1.02 (0.75--1.39)     Adjusted for age and state
                                                                                                                             20--24                 0.98 (0.81--1.18)     
                                                                                                                             25--29                 Referent              
                                                                                                                             30--34                 1.15 (0.93--1.42)     
                                                                                                                             35--39                 1.22 (0.94--1.58)     
                                                                                                                             ≥ 40                   1.27 (0.90--1.69)     
                         \[18\]      2003   LCC      881     3,423                    Denmark                                ≤ 24                   Referent              Adjusted for mother\'s marital status, maternal age, and birth order
                                                                                                                             25--29                 1.08 (0.88--1.32)     
                                                                                                                             ≥ 30                   1.11 (0.90--1.36)     
                         \[36\]^a^   2004   PCC      854     785                      USA                                    ≤ 18                   1.8 (0.9--3.4)        
                                                                                                                             19--22                 Referent              Adjusted for age, race and sampling fractions; tertiles are race specific with cutpoints derived from controls
                                                                                                                             23--27                 3.0 (1.8--5.0)        
                                                                                                                             ≥ 28                   2.5 (1.6--4.0)        
                         \[56\]      2005   MCC      1,060   1,060                    Korea                                  ≤ 24                   Referent              Adjusted for age, family history of breast cancer in first-or second-degree relatives, menopausal status, and lifetime estrogen exposure duration
                                                                                                                             25--29                 1.2 (0.93--1.47)      
                                                                                                                             30--34                 1.4 (1.12--1.83)      
                                                                                                                             ≥ 35                   1.1 (0.83--1.37)      
                         \[20\]      2006   PCC      1,642   1,713                    Poland                                 ≤ 19                   Referent              Adjusted for: age, education, age at menarche, menopausal status and age at menopause, age at first full-term pregnancy, number of full-term pregnancies, family history of breast cancer among first-degree relatives, mammography screening, and current body mass index
                                                                                                                             20--24                 1.02 (0.75--1.39)     
                                                                                                                             25--29                 1.07 (0.79--1.46)     
                                                                                                                             35--39                 1.16 (0.84--1.60)     
                                                                                                                             ≥ 35                   0.91 (0.66--1.27)     
                                                                                                                                                    *P*for trend = 0.76   
                         \[37\]^a^   2006   PCC      1,166   2,105                    USA                                    ≤ 24                   Referent              Adjusted for: age, education, race, body mass index, history of breast benign disease, family history of breast cancer, lactation, age at menarche, age at first full-term pregnancy, age at menopause, and parity
                                                                                                                             25--35                 0.87 (0.67--1.13)     
                                                                                                                             \>35                   0.87 (0.59--1.27)     
  Cohort studies         \[59\]      1995   Cohort   149     75,237                   USA                                    ≤ 24                   Referent              Adjusted for age, education, menopausal status, parity, body mass index, height, smoking, and alcohol drinking
                                                                                                                             25--29                 1.3 (0.8--2.0)        
                                                                                                                             30--34                 1.4 (0.9--2.1)        
                                                                                                                             ≥ 35                   1.2 (0.7--2.0)        
                         \[60\]      1995   Cohort   1,967   384,769                  Sweden                                 ≤ 19                   Referent              Breast cancer mortality; adjusted for age
                                                                                                                             20--24                 0.99 (0.82--1.21)     
                                                                                                                             25--29                 1.00 (0.82--1.22)     
                                                                                                                             30--34                 0.97 (0.79--1.18)     
                                                                                                                             35--39                 1.04 (0.84--1.29)     
                                                                                                                             40--44                 0.93 (0.71--1.21)     
                                                                                                                             ≥ 45                   1.39 (0.91--2.13)     
                         \[49\]^a^   2001   Cohort                                    Sweden                                 Continuous scale       1.07 (0.91--1.27)     Adjusted for spouse age, year of diagnosis, and birth order
                         \[38\]^a^   2001   Cohort   177     3,447                    Filand                                 Continuous scale       \-                    No association
                         \[31\]      2006   Cohort   249     1,024                    USA                                    ≤ 24                   Referent              Hazard ratio; adjusted for age at diagnosis, diagnosis year, stage at diagnosis, and birth order, with exception of birth order, which is adjusted for maternal age
                                                                                                                             25--29                 1.2 (0.9--1.7)        
                                                                                                                             30--34                 1.4 (0.9--1.9)        
                                                                                                                             ≥ 35                   1.7 (1.1--2.8)        
                                                                                                                                                    *P for*trend = 0.03   

^a^We did not include these studies in the meta-analysis because they employed different categories or a continuous scale, or they did not provide the numbers of cases and controls in the original article^b^We included this study in the meta-analysis because we calculated the crude OR using the number of subjects represented the original article. Cohort, cohort study; LCC, case-control study with linkage with population and cancer registry data; LCC-D, case-control study with linkage with population and cancer death certification data; MCC, multicenter case-control study; NCC, nested case-control study in cohort; PCC, population-based case-control study.

In our meta-analyses, we included the 18 studies that reported categorical data and examined three age categories (≤24 \[referent\], 25 to 29, and ≥30 years; Figure [5](#F5){ref-type="fig"}). There was, however, significant study heterogeneity (*P*\_Q test \< 0.01 for 25 to 29 years and for ≥30 years). Heterogeneity was also present across case-control studies and studies published after 2000 (*P*\_Q test \< 0.01). The ORs (95% CI) were 1.18 (1.05 to 1.11) for 25 to 29 years and 1.23 (1.07 to 1.15) for ≥30 years across all studies.

![Meta-analysis for the association between maternal age and the risk of breast cancer. The tests for homogeneity and for publication bias in the studies analyzed are as follows. Maternal age 25 to 29 years: Q = 39.40 (17 degrees of freedom), *P*\< 0.01; Begg test, *P*= 0.85; Egger test, *P*= 0.38, Maternal age 30+ years: Q = 67.34 (17 degrees of freedom), *P*\< 0.01; Begg test, *P*= 0.88; Egger test, *P*= 0.07. ^1^The reference for maternal age is ≤24 years old. CI, confidence interval; OR, odds ratio.](bcr1850-5){#F5}

We identified 15 studies (10 case-control and five cohort) that assessed the association between prematurity and breast cancer risk (Table [5](#T5){ref-type="table"}). Most studies did not observe a significant relationship \[[@B13]-[@B16],[@B20],[@B25],[@B29],[@B31],[@B33],[@B40],[@B42],[@B45]\]. Two studies found that extreme prematurity was associated with an increased risk (OR 3.96 \[95% CI 1.46 to 10.81\] for ≤32 weeks relative to ≥33 weeks \[[@B32]\], and SIR (standardized incidence ratio) 6.7 \[95% CI 1.4 to 19.5\] for \<31 weeks \[[@B62]\]). In contrast, another study \[[@B34]\] found that longer gestation was associated with a significantly increased risk (OR 8.4 \[95% CI 1.3 to 54.4\] for ≥40 weeks relative to ≤32 weeks).

###### 

Table 5 Studies assessing the association of premature birth and the risk of breast cancer

  Type of study          Author        Year   Design    Cases   Controls (or cohort)   Country/place of study   Gestational age (weeks)   OR (95% CI)          Comments
  ---------------------- ------------- ------ --------- ------- ---------------------- ------------------------ ------------------------- -------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Case-control studies   \[42\]^a^     1988   PCC       153     461                    USA                      25--32                    1.16 (0.50--1.54)    Matched analysis
                                                                                                                33--40                    Referent             
                         \[13\]^b^     1996   NCC       571     1,525                  USA                      Categorical                                    Adjusted for age
                                                                                                                 40                       Referent             
                                                                                                                 38--39                   0.76 (0.44--1.32)    
                                                                                                                 36--37                   0.96 (0.59--1.56)    
                                                                                                                Binomial                                       
                                                                                                                 ≥ 37                     Referent             
                                                                                                                 ≤ 36                     0.82 (0.37--1.82)    
                         \[14\]        1996   PCC       1123    1371                   USA                      Nonpreterm                Referent             Adjusted for age, menopausal status, and maternal smoking
                                                                                                                Preterm                   1.1 (0.5--2.1)       
                         \[32\]^a^     1997   NCC       1,010   2,625                  Sweden                   ≥ 33                      Referent             Adjusted for maternal age, matermal socioeconomic status, maternal parity, maternal pre-eclampsia or eclampsia, neonatal jaundice, severe prematurity, twin, and birth weight
                                                                                                                ≤ 32                      3.96 (1.46--10.81)   
                         \[33\]^b^     1998   PCC       502     433                    USA                      ≥ 43                      1.5 (0.8--2.6)       Crude ORs
                                                                                                                37--42                    Referent             
                                                                                                                ≤ 36                      0.9 (0.5--1.8)       
                         \[15\]^a,b^   2000   LCC       480     2,854                  USA                      ≥ 37                      Referent             Crude ORs
                                                                                                                33--36                    1.34 (0.85--2.13)    
                                                                                                                ≤ 32                      0.55 (0.19--1.57)    
                         \[34\]^a,b^   2001   LCC       87      87                     Sweden                   ≥ 40                      8.4 (1.3--54.4)      Matched analysis by conditional logistic regression
                                                                                                                37--40                    3.4 (0.7--17.0)      
                                                                                                                33--36                    3.5 (0.7--17.5)      
                                                                                                                ≤ 32                      Referent             
                         \[25\]^a^     2003   LCohort   127     (1,483)                Sweden                   ≥ 33                      1.08 (0.64--1.70)    Standardized incidence ratio (expected/observed)
                                                                                                                ≤ 32                      0.92 (0.57--1.41)    
                         \[45\]^a,b^   2004   LCC       2,471   9,801                  USA                      ≥ 37                      Referent             Adjusted for age and maternal age at first birth
                                                                                                                32--36                    0.91 (0.72--1.13)    
                                                                                                                ≤ 31                      1.43 (0.90--2.28)    
                         \[20\]^b^     2005   PCC       1,424   1,457                  Poland                   ≥ 37                      Referent             Adjusted for age, education, age at menarche, menopausal status and age at menopause, age at first full-term pregnancy, number of full-term pregnancies, family history of breast cancer among first-degree relatives, mammography screening, and current body mass index
                                                                                                                ≤ 36                      1.01 (0.75--1.32)    
  Cohort studies         \[62\]^c^     2000   LCohort   12      273                    Sweden                   35                        0.2 (0.01--1.3)      Standardized incidence ratio
                                                                                                                33--34                    0.7 (0.1--2.0)       
                                                                                                                31--32                    2.3 (0.7--5.3)       
                                                                                                                \<31                      6.7 (1.4--19.5)      
                         \[16\]^c^     2001   LTCCS     2,265   9,060                  Sweden                   33--36                    Referent             Crude ORs
                                                                                                                37--38                    1.8 (0.83--4.0)      
                                                                                                                40--44                    2.0 (0.88--4.6)      
                         \[29\]^c^     2005   LCohort   367     5,346                  Sweden                   1 week increase           \<50 years           
                                                                                                                                          0.94 (0.83--1.07)    
                         \[40\]^c^     2006   Cohort    97      5,847                  USA                      \<39                      0.77 (0.42--1.4)     Adjusted for age
                                                                                                                39                        1.38 (0.78--2.4)     
                                                                                                                40                        Referent             
                                                                                                                41+                       1.33 (0.67--2.6)     
                         \[31\]^b^     2006   Cohort    249     1024                   USA                      ≥ 43                      0.7 (0.2--2.7)       Adjusted for: age at diagnosis, diagnosis year, stage at diagnosis, and birth order, with exception of birth order, which is adjusted for maternal age
                                                                                                                37--42                    Referent             
                                                                                                                \<37                      1.4 (0.7--2.9)       
                                                                                                                                          *P*for trend = 0.3   

Cohort, cohort study; LCC, case-control study with linkage with population and cancer registry data; LTCCS, twin case-control study by using linkage with birth and cancer registry data; NCC, nested case-control study in cohort; PCC, population-based case-control study. ^a^We included this study in the meta-analysis with categories of ≥33 versus ≤32 months (reference). ^b^We included this study in the meta-analysis with categories of ≥37 versus ≤36 months (reference). ^c^We did not include these studies in the meta-analysis because they employed different categories or a continuous scale, or they did not provide the numbers of cases and controls in the report.

There was no significant heterogeneity across studies (*P*-Q test = 0.55), whereas we found no association between prematurity (≤36 weeks) and risk (OR 1.04 \[95% CI 0.92 to 1.18\]; Figure [6](#F6){ref-type="fig"}). However, a strong publication bias was observed (*P*-Egger test = 0.03 and *P*-Begg test = 0.11; Figure [7](#F7){ref-type="fig"}). A significant publication bias occurred because three studies with smaller standard errors of log RR \[[@B15],[@B16],[@B34]\] reported RRs near 1.0, whereas five studies with larger standard errors \[[@B13],[@B20],[@B31],[@B33],[@B45]\] reported substantially reduced RRs. When the analysis was performed for extreme prematurity (≤32 weeks), heterogeneity was also evident across the studies (*P*-Q test = 0.04), and the association was not significant (OR 1.20 \[95% CI 0.74 to 1.95\]).

![Meta-analysis of studies assessing the association of prematurity and risk for breast cancer. The tests for homogeneity and for publication bias in the studies analyzed are as follows. Category 36+: Q = 5.91 (7 degrees of freedom), *P*= 0.55; Begg test, *P*= 0.11; Egger test, *P*= 0.03. Category 32+: Q = 10.10 (4 degrees of freedom), *P*= 0.04; Begg test, *P*= 0.09; Egger test, *P*= 0.40. ^1^Category of prematurity (week): ≤36 versus ≥37 (reference). ^2^Category of prematurity (week): ≤32 versus ≥33 (reference). CI, confidence interval; OR, odds ratio.](bcr1850-6){#F6}

![Begg\'s funnel plot for publication bias in meta-analysis of premature birth and breast cancer risk. Premature birth (gestational age ≤36 weeks) was compared with gestational age ≥37 weeks. Egger test, *P*= 0.03; Begg test, *P*= 0.11. rr, relative risk; s.e., standard error.](bcr1850-7){#F7}

We examined 13 studies (eight case-control and five cohort) that assessed the association between twin status and risk (Table [6](#T6){ref-type="table"}). Most studies identified a slightly increased risk among twins \[[@B15],[@B31],[@B32],[@B43],[@B45],[@B58],[@B63]-[@B66]\], with five studies demonstrating significant associations \[[@B31],[@B58],[@B64]-[@B66]\]. In contrast, some studies observed a slightly reduced risk \[[@B14],[@B20],[@B67]\], with one of the risks being marginally significant \[[@B67]\]. Seven studies \[[@B20],[@B32],[@B58],[@B63],[@B65],[@B66]\] had information on zygosity. Of these studies, two \[[@B58],[@B63]\] used the twins\' sex as a proxy for zygosity. For monozygotic twins, a reduction in risk was significant in one study \[[@B68]\]. Most studies failed to observe an association \[[@B20],[@B32],[@B58],[@B63],[@B65],[@B66]\]. Three studies reported a significantly increased risk associated with being a dizygotic twin \[[@B58],[@B65],[@B66]\], whereas other studies reported no association \[[@B20],[@B32],[@B63],[@B67]\] (Figure [8](#F8){ref-type="fig"}).

###### 

Studies assessing the association of twinship with risk for breast cancer

  Type of study          Ref.        Year   Design     Cases   Controls (or cohort)   Country/place of study   Category          OR (95% CI)         Comments
  ---------------------- ----------- ------ ---------- ------- ---------------------- ------------------------ ----------------- ------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Case-control studies   \[63\]^a^   1992   MCC        870     2,741                  UK, USA                  Singleton         Referent            Adjusted for age, study center, parity, age at first birth, age at menarche, height, body mass index, maternal age at birth, birth order, and menopausal status
                                                                                                               Twinship          1.40 (0.77--2.55)   
                                                                                                               Singleton         Referent            
                                                                                                               Monozygote twin   1.30 (0.58--2.92)   
                                                                                                               Dizygote twin     1.54 (0.64--3.71)   
                         \[14\]      1996   PCC        1,134   1,380                  USA                      Age 21--45                            Adjusted for age, menopausal status, and maternal smoking
                                                                                                                Singleton        Referent            
                                                                                                                Twinship         0.6 (0.3--1.3)      
                                                                                                               Age 50--64                            
                                                                                                                Singleton        Referent            
                                                                                                                Twinship         0.9 (0.4--2.2)      
                         \[58\]^a^   1997   PCC        2,150   1,961                  USA                      Singleton         Referent            Adjusted for age, study site, family history of breast cancer, breast biopsy, a combination variable including number of full-term births and age at first full-term pregnancy, age at menarche, menopausal status, body mass index, average lifetime alcohol consumption, and the number of mammograms
                                                                                                               Twinship          1.6 (1.0--2.7)      
                                                                                                               Singleton         Referent            
                                                                                                               Monozygote twin   1.39 (0.7--2.6)     
                                                                                                               Dizygote twin     2.06 (1.0--4.5)     
                         \[32\]      1997   NCC        1,068   2,727                  Sweden                   Singleton         Referent            Adjusted for maternal age, matermal socioeconomic status, maternal parity, maternal pre-eclampsia or eclampsia, neonatal jaundice, severe prematurity, twin, and birth weight
                                                                                                               Twinship          1.3 (0.8--2.1)      
                                                                                                               Singleton         Referent            
                                                                                                               Monozygote twin   0.7 (0.2--2.2)      
                                                                                                               Dizygote twin     1.5 (0.8--2.7)      
                         \[15\]      2000   LCC        481     2,863                  USA                      Singleton         Referent            Crude ORs
                                                                                                               Twinship          1.04 (0.51--2.11)   
                         \[43\]      2001   LCC        319     768                    USA                      Singleton         Referent            Crude ORs
                                                                                                               Twinship          1.6 (0.2--10.1)     
                         \[45\]      2004   LCC        2,522   10,052                 USA                      Singleton         Referent            Adjusted for age and maternal age at first birth
                                                                                                               Twinship          1.77 (1.05--2.97)   
                         \[20\]      2005   PCC        2,338   2,476                  Poland                   Singleton         Referent            Adjusted for age, education, age at menarche, menopausal status and age at menopause, age at first full-term pregnancy, number of full-term pregnancy, family history of breast cancer among first-degree relatives, mammography screening, and current body mass index
                                                                                                               Twinship          0.76 (0.49--1.16)   
                                                                                                               Singleton         Referent            
                                                                                                               Monozygote twin   0.90 (0.53--1.52)   
                                                                                                               Dizygote twin     0.58 (0.23--1.47)   
                                                                                                                                                     
  Cohort studies         \[64\]      1980   LTCohort   270     (16,922)               Denmark                  Twinship          1.1 (1.0--1.2)      Observed/expected ratio (95% CI)
                         \[65\]      1995   LTCohort   740     (25,541)               Sweden                   Twinship          1.1 (1.0--1.1)      Observed/expected ratio (95% CI)
                                                                                                               Monozygote twin   1.0 (0.9--1.2)      
                                                                                                               Dizygote twin     1.1 (1.0--1.2)      
                         \[67\]      1999   LTCohort   245     (13,176)               Finland                  Twinship          0.91 (0.81--1.00)   Observed/expected ratio (95% CI)
                                                                                                               Monozygote twin   0.76 (0.59--0.97)   
                                                                                                               Dizygote twin     0.98 (0.84--1.10)   
                         \[66\]      2000   Cohort     1,230   (29,197)               USA                      Singleton         Referent            Adjusted for age, education, family history of breast cancer, age at menarche, age at first birth, height, current body mass index, body mass index at age 18, waist:hip ratio, alcohol drinking, and hormone replacement therapy
                                                                                                               Twinship          1.72 (1.22--2.42)   
                                                                                                               Singleton         Referent            
                                                                                                               Monozygote twin   1.04 (0.43--2.5)    
                                                                                                               Dizygote twin     1.77 (1.16--2.7)    
                         \[31\]      2006   Cohort     249     1,024                  USA                      Singleton         Referent            Adjusted for age at diagnosis, diagnosis year, stage at diagnosis, and birth order, with exception of birth order, which is adjusted for maternal age
                                                                                                               Twinship          2.5 (1.0--6.2)      

^a^Authors used the female twins as the proxy of the monozygote twin and the female twin with male twin as the proxy of the dizygote twin. Cohort, cohort study; LCC, case-control study with linkage with population and cancer registry data; LTCohort, twin cohort study by using linkage with birth and cancer registry data; MCC, multicenter case-control study; NCC, nested case-control study in cohort; PCC, population-based case-control study.

![Meta-analysis for the association between twinship and risk for breast cancer. The tests for homogeneity and for publication bias in the studies analyzed are as follows. Twinship: Q = 18.79 (13 degrees of freedom), *P*= 0.13; Begg test, *P*= 0.78; Egger test, *P*= 0.24. Monozygote twin: Q = 5.79 (6 degrees of freedom), *P*= 0.45; Begg test, *P*= 0.55; Egger test, *P*= 0.85. Dizygote twin: Q = 12.53 (6 degrees of freedom), *P*= 0.06; Begg test, *P*= 1.0; Egger test, *P*= 0.3. ^1^The authors used the female twins as the proxy for the monozygote twin and the female twin with male twin as the proxy for the dizygote twin. ^2^Women aged 21 to 45 years. ^3^Women aged 50 to 64 years. CI, confidence interval; OR, odds ratio.](bcr1850-8){#F8}

The Q test for heterogeneity was not significant (*P*-Q test = 0.13), and the meta-analysis of 13 studies examining twin status (without regard to zygosity) found an OR of 1.22 (95% CI 1.01 to 1.11). There was no evidence of any publication bias (*P*-Egger test or *P*-Begg test \>0.1). There were little evidence of heterogeneity (*P*-Q test \> 0.1 for monozygotic or dizygotic twins), and breast cancer risk was not significantly increased among either monozygotic (OR 0.95 \[95% CI 0.85 to 1.07\]) or dizygotic (OR 1.17 \[95% CI 0.99 to 1.37\]) twins, albeit based on limited statistical power. In subgroup analysis by study design, cohort studies identified significantly increased risk (OR 1.23 \[95% CI 1.00 to 1.11\]) for breast cancer in twins versus singletons, with no study heterogeneity (*P*-Q test = 0.07). Case-control studies showed no association with twin status (OR 1.39 \[95% CI 0.91 to 1.12\]). There was no evidence of any publication bias (*P*-Egger test or *P*-Begg test \> 0.05) among the case-control or cohort studies. In subgroup analysis by study design and zygosity, there were no heterogeneity in studies (*P*-Q test \> 0.1). In subgroup analysis by study year, significant heterogeneity by publication year was identified (*P*= 0.01), and the OR (95% CI) for studies published before 2000 was 1.06 (0.97 to 1.47), whereas the OR (95% CI) for studies published in 2000 or later was 1.27 (1.03 to 1.58).

We identified nine studies that assessed the association between maternal or paternal smoking and risk (Table [7](#T7){ref-type="table"}). Two cohort studies reported nonsignificantly reduced risks associated with maternal smoking (OR 0.49 \[95% CI 0.29 to 1.03\] \[[@B68]\]; OR 0.8 \[95% CI 0.5 to 1.1\] \[[@B31]\]), whereas a case-control study \[[@B43]\] identified a significant positive association (age-adjusted OR 2.7 \[95% CI 1.1 to 6.3\]), although its crude OR was not statistically significant (OR 1.1 \[95% CI 0.7 to 1.7\]). The majority of studies, however, identified no associations with maternal \[[@B14],[@B20],[@B33],[@B35],[@B58],[@B69]\] or paternal \[[@B20],[@B35],[@B69]\] smoking during pregnancy.

There was no heterogeneity or publication bias (*P*-Q test \> 0.05, *P*-Egger test and *P*-Begg test \> 0.1 among all studies, case-control or cohort). The meta-analysis for maternal smoking (Figure [9](#F9){ref-type="fig"}) found no significant association with risk (OR 0.98 \[95% CI 0.86 to 1.13\]), although cohort studies \[[@B40],[@B68]\] noted a significant negative association with maternal smoking (OR 0.59 \[95% CI 0.41 to 0.85\]).

###### 

Studies assessing the association of maternal or paternal smoking and the risk of breast cancer

  Type of study          Ref.        Year   Design   Cases   Controls (or cohort)   Country/place of study   Smoking status               OR (95% CI)         Comments
  ---------------------- ----------- ------ -------- ------- ---------------------- ------------------------ ---------------------------- ------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Case-control studies   \[69\]      1996   PCC      53      470                    USA                      Maternal smoking                                 Crude ORs
                                                                                                              No                          Referent            
                                                                                                              Yes                         0.9 (0.4--2.1)      
                                                                                                             Paternal smoking                                 
                                                                                                              No                          Referent            
                                                                                                              Yes                         1.3 (0.9--1.7)      
                         \[14\]      1996   PCC      1,086   1,321                  USA                      Maternal smoking                                 Adjusted for age, menopausal status, and maternal smoking; OR (95% CI) for maternal smoking among early-onset breast cancer patients (≤ 30 years old) was 1.9 (1.0--3.4)
                                                                                                             Age 21--45 years                                 
                                                                                                              No                          Referent            
                                                                                                              Yes                         1.1 (0.9--1.3)      
                                                                                                             Age 50--64 years                                 
                                                                                                              No                          Referent            
                                                                                                              Yes                         1.3 (0.9--2.1)      
                         \[58\]      1997   PCC      522     484                    USA                      Maternal smoking                                 Adjusted for age, study site, family history of breast cancer, breast biopsy, a combination variable including number of full-term births and age at first full-term pregnancy, age at menarche, menopausal status, body mass index, average lifetime alcohol consumption, and the number of mammograms
                                                                                                              No                          Referent            
                                                                                                              Yes                         1.1 (0.8--1.4)      
                         \[33\]      1998   PCC      507     433                    USA                      Maternal smoking                                 Crude ORs
                                                                                                              No                          Referent            
                                                                                                              Yes                         1.1 (0.9--1.5)      
                         \[43\]      2001   LCC      319     768                    USA                      Maternal smoking                                 Adjusted for attained age
                                                                                                              No                          Referent            
                                                                                                              Yes                         2.7 (1.1--6.3)      
                         \[35\]^a^   2002   PCC      1,535   1,534                  USA                      Smoking                                          Adjusted for age and residential regions (states)
                                                                                                              No                          Referent            
                                                                                                              Paternal smoking            1.00 (0.88--1.13)   
                                                                                                              Maternal/parental smoking   1.10 (0.84--1.42)   
                         \[20\]      2005   PCC      2380    2,497                  Poland                   Maternal smoking                                 Unadjusted; recalculated
                                                                                                              No                          Referent            
                                                                                                              Yes (any exposure)          1.19 (0.97--1.47)   
                                                                                                             Paternal smoking                                 
                                                                                                              No                          Referent            
                                                                                                              Yes (any exposure)          0.90 (0.77--1.05)   
  Cohort studies         \[31\]      2006   Cohort   249     1,024                  USA                      Maternal smoking             Referent            Adjusted for age at diagnosis, diagnosis year, stage at diagnosis, and birth order, with exception of birth order, which is adjusted for maternal age Crude relative rates
                                                                                                              No                          0.8 (0.5--1.1)      
                                                                                                              Yes (any exposure)                              
                         \[68\]      2005   Cohort   42      (3,989)                USA                      Maternal smoking                                 
                                                                                                              No                          Referent            
                                                                                                              Yes (any exposure)          0.49 (0.29--1.03)   
                                                                                                              ≤ 15 cigarettes a day       0.33 (0.12--0.94)   
                                                                                                              \>15                        0.68 (0.26--1.73)   

^a^Titus-Ernstoff and coworkers \[35\] classified three categories: nonparental smoking, either paternal or maternal smoking only or both parents smoking during pregnancy. Thus, in this study, the maternal or both parents smoking versus nonparental smoking can be regarded as maternal smoking versus no maternal smoking. Cohort, cohort study; LCC, case-control study by linkage with population data and cancer registry data; PCC, population-based case-control study.

![Meta-analysis for the association of maternal smoking during pregnancy with risk for subsequent breast cancer. The tests for homogeneity and for publication bias in the studies analyzed are as follows: Q = 16.90 (9 degrees of freedom), *P*= 0.06; Begg test, *P*= 0.59; Egger test, *P*= 0.31. ^1^Titus-Ernstoff and coworkers \[35\] classified three categories: nonparental smoking, paternal or maternal smoking only or both parents smoking during pregnancy. The odds ratios (ORs) of father smoking on breast cancer risk was almost unity (OR 1.0, 95% confidence intrval \[CI\] 0.9 to 1.1). Thus, in this study, the mother smoking and both parents smoking versus nonparental smoking can be considered to the maternal smoking versus no maternal smoking. ^2^Women aged 21 to 45 years. ^3^Women aged 50 to 64 years.](bcr1850-9){#F9}

Discussion
==========

The main finding of our meta-analysis was that heavier birth weight was associated with increased breast cancer risk (18% increased risk for the heaviest weight). Twin status was associated with 1.2-fold higher risk for breast cancer relative to a singleton birth. Although we found some evidence of increased risk associated with older maternal age (OR 1.16 for maternal age ≥30 years), there were heterogeneous findings across study designs.

Most studies identified an increased risk for breast cancer with heavier birth weight, with the association being particularly strong for premenopausal or early-onset breast cancers \[[@B14],[@B22],[@B29],[@B30]\]. Our result was similar to the findings of a recent meta-analysis of 26 studies, which revealed that high birth weight was associated with a RR of 1.23 and restricted to premenopausal women (OR 1.25 \[95% CI 1.14 to 1.38) \[[@B70]\]. This analysis grouped birth weight into two categories (classified into high and low birth weight in each study, regardless of specific weight in terms of grams), preventing evaluation of dose-response relationships. We did in fact observe evidence of a dose-response relationship of risk with birth weight, although this was based on a relatively small number of studies involving three or four categories.

Although some studies identified a J-shaped relationship between birth weight and breast cancer risk \[[@B12],[@B14],[@B15],[@B18],[@B25],[@B33],[@B35],[@B37],[@B45]\], others failed to note an increased risk associated with very low birth weights. A recent study involving 3,066 breast cancer patients and 106,504 comparison individuals in a Danish cohort also found no elevated risk among those with very low birth weights \[[@B71]\]. Similarly, our meta-analysis provided little evidence of increased risk for very low birth weights.

Although the mechanisms underlying the association between high birth weight and breast cancer risk remain unclear, it has been suggested that heavier birth weights may result from increased *in utero*exposuresto factors such as insulin-like growth factor-I or estrogens \[[@B72]-[@B76]\]. These substances may act as mitogens by increasing the likelihood of genetic mutations \[[@B75],[@B77]\]. However, several studies have failed to find any correlation between umbilical cord estrogen levels and birth weight \[[@B78],[@B79]\]. One study, however, reported a significant positive relationship with estriol \[[@B80]\]. Further studies should be undertaken to assist in the resolution of these conflicting data.

Our analysis found no association of breast cancer risk with birth orders between 2 and 4, but we did note a somewhat reduced risk associated with higher birth orders (at least 5), although the results were heterogeneous across studies. Biologically, pregnancy estrogen levels appear to be higher during first pregnancies and decline in successive pregnancies \[[@B81]\]. Furthermore, cord blood levels of estradiol, estrone, and progesterone are lower for later born than first born children \[[@B82]\]. These findings suggest that the reduced risk associated with higher birth orders may relate to lower estrogen levels. However, evidence supporting birth order as a risk factor for breast cancer is limited, with further investigations needed to evaluate dose-response relationships more fully.

In our meta-analysis, we found some evidence that having been born to an older mother was associated with higher breast cancer risk, although the results were heterogeneous across studies. Our data failed to support the previous studies that suggested a J-shaped relationship between maternal age and breast cancer risk. It was previously suggested that older maternal age may have an adverse effect on the primordial mammary gland of their daughters because of altered hormonal profiles \[[@B37]\] or may linked to the epigenetic change of mtDNA which can lead to breast carcinogenesis by oocyte inheritance \[[@B83]\]. However, the two studies that examined pregnancy estrogen levels according to maternal age found that both total estrogen and estradiol levels were lowest in youngest mothers (\<20 years of age), highest in those aged 20 to 24 years, and intermediate in mothers over 25 years of age \[[@B78],[@B81]\]. Thus, it remains unclear from both our meta-analysis as well as from biologic data whether maternal age is a proxy for estrogen or estradiol exposure to fetus. Although it has been suggested that older paternal age may cause germ cell mutations, previous epidemiologic studies have failed to support an association \[[@B35],[@B20],[@B69],[@B82],[@B84],[@B85]\]. Because the purpose of this study was to evaluate whether the intrauterine hormone environment affects subsequent breast cancer risk, our meta-analysis did not include paternal age.

We observed no association between prematurity and breast cancer risk. Biologically, women having abruptio placentae or an extremely premature birth (\<32 week) have been shown to have elevated levels of human chorionic gonadotropin and α-fetoprotein, which could inhibit the differentiation of stem cells in human breast tissue cells \[[@B15]\]. Gestational age is related to birth weight, of course, because birth weights in infants born prematurely are lower than those in infants born at term \[[@B13]\].

Twin pregnancies are associated with an approximate doubling of estrogen levels compared with singleton pregnancies \[[@B86],[@B87]\]. Dizygotic twin pregnancies have elevated levels of estrogens and gonadotropins \[[@B88]-[@B90]\]. It has therefore been postulated that twins, especially dizygotic twins, could be at an elevated risk for breast cancer. In general, our results did not support differences in risk between monozygotic and dizygotic twins, and there was evidence that risk estimates published after 2000 were qualitatively different from those of earlier studies.

Studies of parental smoking, especially maternal smoking, and daughter\'s breast cancer risk have yielded inconsistent results. Biologically, maternal smoking, rather than paternal smoking, has a greater impact on the fetus. In the meta-analytic results, both factors failed to exhibit a significant association with risk. Some studies have reported that maternal smoking in pregnancy reduces serum estrogen levels \[[@B91],[@B92]\]. A recent experimental study reported that both estradiol-17β levels and progesterone:estradiol-17β ratios were reduced in pregnant mice exposed to cigarette smoke \[[@B93]\]. However, the relevance of these findings to humans is unclear.

These meta-analyses are based on results from studies involving heterogeneous designs and methodology. We did note between-study heterogeneity for the associations of birth order, maternal age, and twin status. To resolve the heterogeneous findings, we considered the influence of study design and the date of study publication on the results by subgroup analyses. However, heterogeneity in studies could only be explained partially.

Effects of maternal age, birth order, prematurity (cut-off value 32 weeks), and maternal smoking were found to be heterogeneous across study designs, but birth weight and twinning were comparable. Self-reported measures of perinatal factors may be vulnerable to misclassification biases, with differential or nondifferential effects \[[@B94],[@B95]\]. Because studies based on data linkage to medical records have a lower chance of misclassification bias, we conducted subgroup meta-analyses stratified by source of information (data linkage versus self-report) and found no substantial differences in the results. Although the completeness of records is a critical factor in evaluating biases in studies based on data linkage, most papers did not provide details about the completeness of records. We also conducted subgroup meta-analyses stratified by publication year. Only twin status exhibited significant heterogeneity according to publication year (\<2000 versus ≥2000).

Our findings may be somewhat inflated because of our dependence on crude rather than adjusted ORs or RRs. A possible misclassification bias for zygosity might have resulted in studies that used sex as a proxy for zygosity \[[@B96]\]. Because this bias would probably attenuate associations, additional investigations are needed to determine the extent of any true association of risk with twin status.

Conclusion
==========

It has been hypothesized that certain perinatal factors, including birth weight and order, twin pregnancies, prematurity, maternal age, and smoking, may reflect higher estrogenic environments *in utero*, thereby increasing the subsequent risk of breast cancer. Findings of an increase in breast cancer risk among daughters exposed to diethylstilbestrol *in utero*supports this hypothesis \[[@B97],[@B98]\]. Although the current meta-analysis found evidence that higher birth weights are associated with increased breast cancer risk, older maternal age and twin status were less convincingly related, and birth order and prematurity appeared unrelated. Greater birth weights have been attributed to higher maternal estrogens levels, which could affect fetal development \[[@B72]-[@B74]\] through epigenetic modifications of breast stem cells \[[@B1],[@B99],[@B100]\]. Although our findings regarding birth weight support the hypothesis that higher estrogen exposures *in utero*may be involved in the subsequent development of breast cancer, further biologic data are needed to elucidate the relationship fully.
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